Year: 2026
Type: article
Abstract: We are four years into the global mpox outbreak with continued widespread transmission of the Clade 2b strain, and more recently transmission of Clade 1b mpox outside of sub-Saharan Africa. We have no proven therapeutics for mpox other than supportive care. Most countermeasures used during the outbreak were developed for smallpox and approved without human efficacy data for mpox.1 We are now faced with an ongoing, smouldering outbreak, with low case counts, that makes vaccine and treatment trials challenging to enrol.
Source: EBioMedicine
Authors: Timothy Wilkin, Jason Zucker
Language: English
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: monkeypox, mpox outbreak, sub-Saharan Africa
Open Access status: gold
Estimated APC paid: $5,780
OpenAlex ID: W7236414084
